The Cardiac Lipidome in Models of Cardiovascular Disease

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Medicine
• Analytical Chemistry

Background:

• Cardiovascular disease (CVD) is a major global health concern, with lipids playing a critical role in cardiac function and disease pathogenesis.
• Fatty acids (FA) are essential for energy but also implicated in the development of heart failure and other CVDs.
• Comprehensive lipidomic analysis is crucial for understanding the complex roles of lipids in cardiovascular health and disease.

Purpose of the Study:

• To review recent mass spectrometry-based studies analyzing cardiac lipid profiles in various CVD models.
• To identify novel biomarkers and molecular mechanisms underlying CVD development and progression through lipidomic alterations.
• To explore the potential of lipidomic insights for developing new CVD therapeutics.

Main Methods:

• Utilized mass spectrometry (MS) for comprehensive analysis of diverse lipid species in cardiac samples.
• Reviewed studies focusing on models of myocardial infarction, obesity, diabetic cardiomyopathy, and dilated cardiomyopathy.
• Integrated lipidomic data to understand alterations associated with different CVD conditions.

Main Results:

• Significant alterations in cardiac lipid profiles were observed across different models of cardiovascular disease.
• Mass spectrometry enabled the detailed characterization of numerous lipid species, revealing complex changes.
• Identified specific lipid alterations potentially serving as biomarkers for CVD diagnosis and progression.

Conclusions:

• Cardiac lipidomic profiling using mass spectrometry provides valuable insights into CVD pathogenesis.
• Understanding these lipid alterations can lead to the discovery of novel biomarkers for cardiovascular disease.
• This knowledge can guide the development of targeted therapeutic strategies for treating cardiovascular conditions.